Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam (Q38075482)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 January 2013
edit
Language Label Description Also known as
English
Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam
scientific article published on 18 January 2013

    Statements

    Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam (English)
    Michael N Dudley
    Paul G Ambrose
    William A Craig
    Mary Jane Ferraro
    Antimicrobial Susceptibility Testing Subcommittee of the Clinical and Laboratory Standards Institute
    18 January 2013
    1301-1309

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit